REVIEW
|
doi:10.20944/preprints202309.0353.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
FDA; Omics technology; Pharmacodynamic biomarkers; biosimilars; Proteomics; Gycomis; Re-ceptor Binding; Pharmacokinetics
Online: 6 September 2023 (03:32:11 CEST)